Table 1. Tumour and patient characteristics at trial entry.

	N (%)
Age
Median (IQR)	60.7 (49.7, 65.5)
Presentation of disease
Primary	9 (31.0%)
Recurrent	20 (69.0%)
Previous surgery
Yes	22 (75.9%)
No	7 (24.1%)
Pathological T stage
TX	11 (37.9%)
T1	5 (17.2%)
T2	7 (24.1%)
T3	6 (20.7%)
N stage
N0	1 (3.4%)
N1	5 (17.2%)
N2	7 (24.1%)
N3	15 (51.7%)
NX	1 (3.4%)
M Stage
M0 loco-regional	21 (72.4%)
M1 metastatic	8 (27.6%)
Operability at trial entry
Inoperable	20 (69.0%)
Operable	9 (31.0%)

Abbreviation: IQR=interquartile range.